Multi-year CDMO partnership combines AI-led virtual development, precision chemistry and GMP manufacturing to accelerate five high-science APIs across regulated markets
As demand for GLP-1 therapies explodes, India’s drug regulator moves to curb advertising amid rising concerns over misuse, access, and long-term impact
As part of the deal, Red Nucleus also gains indirect ownership of the company’s Indian arm
Collaboration to study integration of AI-enabled VR solutions into medical and nursing curricula
Wholly owned subsidiary KIMS Swastha signs hospital management and sub-lease deal for 210-bed facility, with option to acquire majority stake later
Minister highlights scope for domestic manufacturing during his meeting with Dr Niti Pall, President-elect, International Diabetes Federation
Institute signs four MoUs, launches two products and marks 75 years with renewed focus on lab-to-market commercialisation
The record-setting effort stems from Danone India’s nationwide ‘IRON UP!’ campaign
The JADE trial enrolled 164 U.S. patients who initially received three monthly doses of OLN324 or faricimab, followed by 12 weeks off treatment with retreatment allowed only if disease recurred
Subscribe To Our Newsletter & Stay Updated
